MannKind Corp. (MNKD)
4.075
-0.08
(-1.81%)
USD |
NASDAQ |
Aug 24, 16:00
4.075
0.00 (0.00%)
After-Hours: 20:00
MannKind Price : 4.075 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 4.28 | 4.355 | 4.11 | 4.15 | 3.205M |
| Aug 20, 2026 | 4.35 | 4.36 | 4.135 | 4.26 | 3.416M |
| Aug 19, 2026 | 4.10 | 4.40 | 4.10 | 4.395 | 5.435M |
| Aug 18, 2026 | 3.87 | 4.10 | 3.87 | 4.07 | 4.601M |
| Aug 17, 2026 | 3.85 | 3.94 | 3.804 | 3.90 | 3.322M |
| Aug 14, 2026 | 3.74 | 3.85 | 3.69 | 3.85 | 2.855M |
| Aug 13, 2026 | 3.88 | 3.895 | 3.63 | 3.73 | 5.240M |
| Aug 12, 2026 | 3.86 | 3.92 | 3.835 | 3.85 | 3.056M |
| Aug 11, 2026 | 3.91 | 3.98 | 3.815 | 3.84 | 4.498M |
| Aug 10, 2026 | 4.065 | 4.08 | 3.88 | 3.93 | 4.157M |
| Aug 07, 2026 | 3.91 | 4.15 | 3.854 | 4.11 | 5.048M |
| Aug 06, 2026 | 3.815 | 3.93 | 3.69 | 3.89 | 9.306M |
| Aug 05, 2026 | 3.925 | 4.14 | 3.90 | 4.10 | 6.834M |
| Aug 04, 2026 | 3.82 | 4.00 | 3.78 | 3.96 | 5.118M |
| Aug 03, 2026 | 3.96 | 3.96 | 3.78 | 3.80 | 5.277M |
| Jul 31, 2026 | 4.09 | 4.141 | 3.85 | 3.91 | 5.404M |
| Jul 30, 2026 | 3.90 | 4.12 | 3.88 | 4.11 | 4.141M |
| Jul 29, 2026 | 3.90 | 3.955 | 3.82 | 3.85 | 3.587M |
| Jul 28, 2026 | 3.98 | 4.00 | 3.841 | 3.91 | 3.657M |
| Jul 27, 2026 | 4.21 | 4.235 | 3.95 | 3.95 | 5.326M |
| Jul 24, 2026 | 4.06 | 4.23 | 3.98 | 4.13 | 9.444M |
| Jul 23, 2026 | 3.73 | 3.91 | 3.710 | 3.89 | 2.942M |
| Jul 22, 2026 | 4.06 | 4.07 | 3.805 | 3.84 | 5.543M |
| Jul 21, 2026 | 3.96 | 4.23 | 3.96 | 4.05 | 4.403M |
| Jul 20, 2026 | 4.03 | 4.10 | 3.975 | 3.98 | 3.025M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| United Therapeutics Corp. | 513.04 |
| ACADIA Pharmaceuticals, Inc. | 29.63 |
| Gilead Sciences, Inc. | 146.76 |
| Vertex Pharmaceuticals, Inc. | 547.74 |
| Ocugen, Inc. | 1.365 |
Price Related Metrics
| PS Ratio | 3.200 |
| Earnings Yield | -3.48% |
| Market Cap | 1.263B |
| Operating PE Ratio | 94.83 |